Insider Trading activities at Acadia Pharmaceuticals Inc (ACAD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acadia Pharmaceuticals Inc (ACAD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acadia Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1070494.

Total stock buying since 2015: $498,574,279.
Total stock sales since 2015: $98,196,016.
Total stock option exercises since 2015: $36,118,690.


 1   2 
27 insiders reported insider trading activities at Acadia Pharmaceuticals Inc (ACAD):
Insider trading activities of 14159, L.p.
Insider trading activities of Brege Laura
Insider trading activities of Miller Eric Alejandro
Insider trading activities of Gray Mary Ann
Insider trading activities of Borer Michael T
Insider trading activities of Ridloff Elena
Insider trading activities of Moore Terrence O
Insider trading activities of Baker Bros. Advisors (gp) Llc
Insider trading activities of Harrigan Edmund
Insider trading activities of Stankovic Srdjan R.
Insider trading activities of Teehan Brendan
Insider trading activities of Kim Austin D.
Insider trading activities of Baker Julian
Insider trading activities of Garofalo Elizabeth A.
Insider trading activities of Iversen Leslie L
Insider trading activities of Daly James M
Insider trading activities of Ndu Adora
Insider trading activities of Davis Stephen
Insider trading activities of Hacksell Uli
Insider trading activities of Yang Michael J.
Insider trading activities of Soland Daniel B
Insider trading activities of Baity Glenn
Insider trading activities of Rasmussen Torsten
Insider trading activities of Kaplan Lester J Ph D
Insider trading activities of Schneyer Mark C.
Insider trading activities of Kihara James
Insider trading activities of Baker Brothers Life Sciences Lp

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Acadia Pharmaceuticals Inc (ACAD).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 63,040 $1,363,346 83,531 $0
2024 0 $0 170,819 $2,985,481 224,875 $0
2023 896,522 $22,719,343 348,454 $8,721,320 494,371 $2,502,250
2022 0 $0 24,229 $483,031 101,113 $0
2021 0 $0 147,095 $7,255,080 171,656 $2,963,961
2020 1,050,000 $33,331,510 560,446 $27,335,888 590,864 $10,548,334
2019 1,562,500 $62,500,000 553,810 $24,758,841 560,039 $11,362,645
2018 12,985,481 $223,134,090 135,879 $4,175,699 149,500 $478,284
2017 0 $0 341,168 $12,872,410 1,797,769 $6,215,059
2016 5,339,326 $156,889,336 79,697 $2,595,187 243,308 $564,092
2015 0 $0 163,975 $5,649,733 212,102 $1,484,065

Table 2. Monthly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 1,600 $41,560 0 $0
2025-08 0 $0 22,000 $554,026 0 $0
2025-06 0 $0 14,446 $314,633 0 $0
2025-05 0 $0 10,825 $210,444 65,733 $0
2025-04 0 $0 3,736 $55,366 7,285 $0
2025-03 0 $0 9,185 $162,407 8,320 $0
2025-02 0 $0 1,248 $24,910 2,193 $0
2024-11 0 $0 24,661 $414,550 47,582 $0
2024-10 0 $0 0 $0 4,381 $0
2024-08 0 $0 51,014 $779,493 0 $0
2024-06 0 $0 975 $14,420 1,893 $0
2024-05 0 $0 19,733 $334,275 78,527 $0
2024-04 0 $0 33,648 $601,288 65,797 $0
2024-03 0 $0 28,288 $506,353 0 $0
2024-02 0 $0 7,447 $183,716 14,246 $0
2024-01 0 $0 5,053 $151,386 12,449 $0
2023-12 0 $0 2,000 $56,600 0 $0
2023-11 0 $0 12,053 $272,879 23,788 $0
2023-10 0 $0 67,932 $1,491,786 144,554 $0
2023-09 0 $0 2,000 $51,760 0 $0
2023-08 0 $0 10,000 $289,970 0 $0
2023-07 0 $0 171,602 $4,797,315 100,000 $2,077,000
2023-06 0 $0 11,474 $281,175 44,653 $0
2023-05 896,522 $22,719,343 45,397 $1,009,193 96,370 $425,250

Table 3. Detailed insider trading at Acadia Pharmaceuticals Inc (ACAD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-02 Garofalo Elizabeth A. Sale 1,600 25.98 41,560
2025-08-18 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 22,000 25.18 554,026
2025-06-04 Brege Laura Sale 14,446 21.78 314,633
2025-05-29 Ndu Adora Option Ex 9,387 .00 0
2025-05-29 Garofalo Elizabeth A. Option Ex 9,387 .00 0
2025-05-29 Daly James M Option Ex 9,387 .00 0
2025-05-29 Brege Laura Option Ex 9,387 .00 0
2025-05-29 Soland Daniel B Option Ex 9,387 .00 0
2025-05-29 Harrigan Edmund Option Ex 9,387 .00 0
2025-05-16 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 2,000 25.00 50,000
2025-05-16 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 4,000 22.50 90,000
2025-05-02 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 3,498 14.60 51,070
2025-05-02 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 1,327 14.60 19,374
2025-05-01 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 6,815 .00 0
2025-05-01 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 2,596 .00 0
2025-04-08 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 2,708 14.82 40,132
2025-04-08 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 1,028 14.82 15,234
2025-04-05 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 5,275 .00 0
2025-04-05 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 2,010 .00 0
2025-03-26 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 3,171 17.05 54,065
2025-03-26 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 1,095 17.05 18,669
2025-03-25 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 6,178 .00 0
2025-03-25 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 2,142 .00 0
2025-03-05 Garofalo Elizabeth A. Sale 4,919 18.23 89,673
2025-02-24 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 773 19.96 15,429
2025-02-24 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 475 19.96 9,481
2025-02-23 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 1,353 .00 0
2025-02-23 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 840 .00 0
2024-11-19 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 10,259 16.81 172,453
2024-11-19 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Sale 10,329 16.81 173,630
2024-11-19 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 4,073 16.81 68,467
2024-11-17 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 19,826 .00 0
2024-11-17 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Option Ex 19,826 .00 0
2024-11-17 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 7,930 .00 0
2024-10-12 Ndu Adora Option Ex 4,381 .00 0
2024-08-19 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 9,733 15.28 148,720
2024-08-19 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Sale 9,534 15.28 145,679
2024-08-19 Davis Stephen (CEO) Sale 31,747 15.28 485,094
2024-06-10 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 975 14.79 14,420
2024-06-08 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 1,893 .00 0
2024-05-29 Ndu Adora Option Ex 6,652 .00 0
2024-05-29 Garofalo Elizabeth A. Option Ex 6,652 .00 0
2024-05-29 Daly James M Option Ex 6,652 .00 0
2024-05-29 Brege Laura Option Ex 6,652 .00 0
2024-05-29 Soland Daniel B Option Ex 6,652 .00 0
2024-05-29 Harrigan Edmund Option Ex 6,652 .00 0
2024-05-02 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 3,503 16.94 59,340
2024-05-02 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Sale 3,477 16.94 58,900
2024-05-02 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 1,326 16.94 22,462
2024-05-02 Davis Stephen (CEO) Sale 11,427 16.94 193,573
2024-05-01 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 6,814 .00 0
2024-05-01 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Option Ex 6,814 .00 0
2024-05-01 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 2,596 .00 0
2024-05-01 Davis Stephen (CEO) Option Ex 22,391 .00 0
2024-04-08 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 2,716 17.87 48,534
2024-04-08 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Sale 2,568 17.87 45,890
2024-04-08 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 1,790 17.87 31,987
2024-04-08 Davis Stephen (CEO) Sale 26,574 17.87 474,877
2024-04-07 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 1,489 .00 0
2024-04-05 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 5,275 .00 0
2024-04-05 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Option Ex 5,024 .00 0
2024-04-05 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 2,010 .00 0
2024-04-05 Davis Stephen (CEO) Option Ex 51,999 .00 0
2024-03-27 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 5,434 17.90 97,268
2024-03-27 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Sale 5,140 17.90 92,005
2024-03-27 Davis Stephen (CEO) Sale 17,714 17.90 317,080
2024-02-26 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Sale 772 24.67 19,045
2024-02-26 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Sale 624 24.67 15,394
2024-02-26 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Sale 474 24.67 11,693
2024-02-26 Davis Stephen (CEO) Sale 5,577 24.67 137,584
2024-02-23 Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) Option Ex 1,353 .00 0
2024-02-23 Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL) Option Ex 1,107 .00 0
2024-02-23 Kihara James (PRINCIPAL ACCOUNTING OFFICER) Option Ex 840 .00 0
2024-02-23 Davis Stephen (CEO) Option Ex 10,946 .00 0
2024-01-08 Teehan Brendan (EVP, COO, Head of Commercial) Sale 731 29.96 21,900
2024-01-08 Kim Austin D. (EVP,General Counsel, Secretary) Sale 590 29.96 17,676
2024-01-08 Davis Stephen (CEO) Sale 3,732 29.96 111,810
2024-01-06 Teehan Brendan (EVP, COO, Head of Commercial) Option Ex 1,287 .00 0
2024-01-06 Kim Austin D. (EVP,General Counsel, Secretary) Option Ex 1,634 .00 0
2024-01-06 Davis Stephen (CEO) Option Ex 9,528 .00 0
2023-12-15 Kihara James (Principal Accounting Officer) Sale 2,000 28.30 56,600
2023-11-20 Schneyer Mark C. (EVP, Chief Financial Officer) Sale 5,108 22.64 115,645
2023-11-20 Teehan Brendan (EVP, COO, Head of Commercial) Sale 4,960 22.64 112,294
2023-11-20 Kihara James (Principal Accounting Officer) Sale 1,985 22.64 44,940
2023-11-17 Schneyer Mark C. (EVP, Chief Financial Officer) Option Ex 9,912 .00 0
2023-11-17 Teehan Brendan (EVP, COO, Head of Commercial) Option Ex 9,912 .00 0
2023-11-17 Kihara James (Principal Accounting Officer) Option Ex 3,964 .00 0
2023-10-12 Ndu Adora (Director) Option Ex 4,381 .00 0
2023-10-06 Kim Austin D. (EVP,General Counsel, Secretary) Sale 16,369 21.96 359,463
2023-10-06 Davis Stephen (CEO) Sale 51,563 21.96 1,132,323
2023-10-05 Kim Austin D. (EVP,General Counsel, Secretary) Option Ex 36,174 .00 0
2023-10-05 Davis Stephen (CEO) Option Ex 103,999 .00 0
2023-09-15 Kihara James (Principal Accounting Officer) Sale 2,000 25.88 51,760
2023-08-21 Schneyer Mark C. (EVP, Chief Financial Officer) Sale 10,000 29.00 289,970
2023-07-14 Davis Stephen (CEO) Sale 100,000 30.04 3,004,400
2023-07-14 Davis Stephen (CEO) Option Ex 100,000 20.77 2,077,000
2023-07-12 Davis Stephen (CEO) Sale 55,104 25.05 1,380,465
2023-07-11 Davis Stephen (CEO) Sale 16,498 25.00 412,450
2023-06-15 Kihara James (Principal Accounting Officer) Sale 4,000 24.15 96,600
2023-06-12 Brege Laura (Director) Sale 4,500 24.87 111,906
2023-06-08 Schneyer Mark C. (EVP, Chief Financial Officer) Sale 974 25.02 24,369
2023-06-08 Schneyer Mark C. (EVP, Chief Financial Officer) Option Ex 1,893 .00 0
2023-06-01 Garofalo Elizabeth A. (Director) Option Ex 8,552 .00 0
2023-06-01 Daly James M (Director) Option Ex 8,552 .00 0
2023-06-01 Brege Laura (Director) Option Ex 8,552 .00 0
2023-06-01 Soland Daniel B (Director) Option Ex 8,552 .00 0
2023-06-01 Harrigan Edmund (Director) Option Ex 8,552 .00 0
2023-05-24 Baker Brothers Life Sciences Lp (Director) Buy 553,263 25.48 14,096,587
2023-05-23 Baker Brothers Life Sciences Lp (Director) Buy 209,053 25.43 5,317,263
2023-05-23 Baker Brothers Life Sciences Lp (Director) Option Ex 25,000 17.01 425,250
2023-05-22 Baker Brothers Life Sciences Lp (Director) Buy 134,206 24.63 3,305,493
2023-05-17 Schneyer Mark C. (EVP, Chief Financial Officer) Sale 15,310 22.50 344,475
2023-05-17 Schneyer Mark C. (EVP, Chief Financial Officer) Option Ex 29,738 .00 0
2023-05-17 Teehan Brendan (EVP, COO, Head of Commercial) Sale 14,869 22.50 334,552
2023-05-17 Teehan Brendan (EVP, COO, Head of Commercial) Option Ex 29,738 .00 0
2023-05-17 Kihara James (Principal Accounting Officer) Sale 5,947 22.50 133,807
2023-05-17 Kihara James (Principal Accounting Officer) Option Ex 11,894 .00 0
2023-05-01 Teehan Brendan (EVP, COO, Head of Commercial) Sale 548 21.18 11,606
2023-05-01 Kim Austin D. (EVP,General Counsel, Secretary) Sale 917 21.18 19,422
2023-05-01 Davis Stephen (CEO) Sale 7,806 21.18 165,331
2023-04-29 Teehan Brendan (EVP, COO, Head of Commercial) Option Ex 1,567 .00 0
2023-04-29 Kim Austin D. (EVP,General Counsel, Secretary) Option Ex 3,005 .00 0
2023-04-29 Davis Stephen (CEO) Option Ex 15,625 .00 0
2023-04-10 Kihara James (Principal Accounting Officer) Sale 523 18.14 9,487
2023-04-07 Kihara James (Principal Accounting Officer) Option Ex 1,489 .00 0
2023-04-06 Schneyer Mark C. (EVP, Chief Financial Officer) Sale 1,916 18.16 34,794
2023-04-06 Teehan Brendan (EVP, COO, Head of Commercial) Sale 1,751 18.16 31,798
2023-04-06 Kihara James (Principal Accounting Officer) Sale 701 18.16 12,730
2023-04-06 Kim Austin D. (EVP,General Counsel, Secretary) Sale 1,456 18.16 26,440
2023-04-06 Davis Stephen (CEO) Sale 8,582 18.16 155,849
2023-04-05 Schneyer Mark C. (EVP, Chief Financial Officer) Option Ex 5,275 .00 0
2023-04-05 Teehan Brendan (EVP, COO, Head of Commercial) Option Ex 5,024 .00 0
2023-04-05 Kihara James (Principal Accounting Officer) Option Ex 2,009 .00 0
2023-04-05 Kim Austin D. (EVP,General Counsel, Secretary) Option Ex 4,773 .00 0
2023-04-05 Davis Stephen (CEO) Option Ex 17,333 .00 0
2023-02-24 Schneyer Mark C. (EVP, Chief Financial Officer) Sale 577 18.78 10,836
2023-02-24 Teehan Brendan (EVP, COO, Head of Commercial) Sale 461 18.78 8,657
2023-02-24 Kihara James (Principal Accounting Officer) Sale 350 18.78 6,573
2023-02-24 Kim Austin D. (EVP,General Counsel, Secretary) Sale 803 18.78 15,080
2023-02-24 Davis Stephen (CEO) Sale 3,851 18.78 72,321
2023-02-23 Schneyer Mark C. (EVP, Chief Financial Officer) Option Ex 1,353 .00 0
2023-02-23 Teehan Brendan (EVP, COO, Head of Commercial) Option Ex 1,107 .00 0
2023-02-23 Kihara James (Principal Accounting Officer) Option Ex 840 .00 0
2023-02-23 Kim Austin D. (EVP,General Counsel, Secretary) Option Ex 2,214 .00 0
2023-02-23 Davis Stephen (CEO) Option Ex 10,945 .00 0
2023-01-09 Teehan Brendan (EVP, COO, Head of Commercial) Sale 532 17.13 9,113
2023-01-09 Kim Austin D. (EVP,General Counsel, Secretary) Sale 589 17.13 10,089
2023-01-09 Davis Stephen (CEO) Sale 3,904 17.13 66,875
2023-01-06 Teehan Brendan (EVP, COO, Head of Commercial) Option Ex 1,286 .00 0
2023-01-06 Kim Austin D. (EVP,General Counsel, Secretary) Option Ex 1,633 .00 0
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ACAD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acadia Pharmaceuticals Inc (symbol ACAD, CIK number 1070494) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.